Study Data from University of Cambridge Provide New Insights into Machine Learning (Exploration and Exploitation Approaches Based On Generative Machine Learning To Identify Potent Small Molecule Inhibitors of Alpha-synuclein Secondary Nucleation).

Předmět:	SMALL molecules MACHINE learning ALPHA-synuclein NERVE tissue proteins NUCLEATION
Zdroj:	Clinical Trials Week; 5/1/2023, p951-951, 1p
Abstrakt:	Keywords: Cambridge; United Kingdom; Europe; Cyborgs; Drugs and Therapies; Emerging Technologies; Health and Medicine; Machine Learning; Nerve Tissue Proteins; Proteins; Small Molecule Inhibitors; Synucleins; alpha-Synuclein EN Cambridge United Kingdom Europe Cyborgs Drugs and Therapies Emerging Technologies Health and Medicine Machine Learning Nerve Tissue Proteins Proteins Small Molecule Inhibitors Synucleins alpha-Synuclein 951 951 1 05/02/23 20230501 NES 230501 2023 MAY 1 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- A new study on Machine Learning is now available. Cambridge, United Kingdom, Europe, Cyborgs, Drugs and Therapies, Emerging Technologies, Health and Medicine, Machine Learning, Nerve Tissue Proteins, Proteins, Small Molecule Inhibitors, Synucleins, alpha-Synuclein. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu